Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
British Journal of Cancer
|
April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
G Nasti, M C Piccirillo, F Izzo, et al.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
Cancer Biology & Therapy
|
July 27, 2010
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial
Gaetano Facchini, Michele Caraglia, Alessandro Morabito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
JAMA Network Open
|
July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
Antonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open
|
January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
C Cardone, A De Stefano, G Rosati, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Journal of Cancer Policy
|
October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients
L Arenare, C Porta, D Barberio, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
British Journal of Cancer
|
April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
G Nasti, M C Piccirillo, F Izzo, et al.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
Cancer Biology & Therapy
|
July 27, 2010
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial
Gaetano Facchini, Michele Caraglia, Alessandro Morabito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
JAMA Network Open
|
July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
Antonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open
|
January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
C Cardone, A De Stefano, G Rosati, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Journal of Cancer Policy
|
October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients
L Arenare, C Porta, D Barberio, et al.
Page
of 4